Our findings unveil an unexplored novel Che-1/miR-590-3p/TAZ axis in MM tumorigenesis by providing a rationale to explore its therapeutic potential in metastatic bone lesions [25–27]. This evidence concerns the gene WWTR1 and Miyoshi myopathy.